Literature DB >> 32429017

Repair of Iliac Crest Defects with a Hydroxyapatite/Collagen Composite.

Koichi Murata1, Shunsuke Fujibayashi1, Bungo Otsuki1, Takayoshi Shimizu1, Shuichi Matsuda1.   

Abstract

STUDY
DESIGN: Retrospective study.
PURPOSE: This study aimed to assess the effect of refilling with hydroxyapatite/collagen (HAp/Col) composite on an iliac crest defect after spinal fusion. OVERVIEW OF LITERATURE: The use of iliac crest bone graft has been the gold standard in spinal fusion for a long time because of its biological and non-immunologic properties. Few reports have addressed how bone defects recover after iliac crest bone harvest following spinal fusion.
METHODS: Cancellous bone was collected from the anterior iliac crest during lateral interbody fusion (LIF), and the bone void of the ilium was refilled with a porous HAp/Col composite. We assessed bone recovery using computed tomography (CT). From the 74 patients who underwent LIF between January 2015 and December 2016, we included 49 patients whose iliac crest could be evaluated using CT at 3 months and 1 year after the surgery.
RESULTS: Bone defects decreased in a time-dependent manner after the surgery. Cortical closure was observed in 28.5% of the cases 3 months after the surgery; at 1 year postoperatively, 95.9% of the patients had cortical closure. Complete repair of the cancellous bone was achieved in 57.1% of the patients at 3 months after the surgery and in 95.9% at 1 year after the surgery. There were no significant hematomas, infections, iliac crest fractures, or soft tissue herniation.
CONCLUSIONS: Radiographic recovery of cortical and cancellous bone defects was achieved with high probability via refilling with HAp/Col composite over the 1-year period.

Entities:  

Keywords:  Bone regeneration; Collagen type 1; Hydroxyapatites; Ilium

Year:  2020        PMID: 32429017     DOI: 10.31616/asj.2019.0310

Source DB:  PubMed          Journal:  Asian Spine J        ISSN: 1976-1902


  2 in total

1.  Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.

Authors:  Jun-Young Choi; Hyun-Jin Park; Sang-Min Park; Chang-Nam Kang; Kwang-Sup Song
Journal:  J Orthop Surg Res       Date:  2022-08-31       Impact factor: 2.677

Review 2.  Novel Surgical Technique for Adolescent Idiopathic Scoliosis: Minimally Invasive Scoliosis Surgery.

Authors:  Sung Cheol Park; Sei Wook Son; Jae Hyuk Yang; Dong-Gune Chang; Seung Woo Suh; Yunjin Nam; Hong Jin Kim
Journal:  J Clin Med       Date:  2022-10-02       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.